on Antimicrobial resistance
Antimicrobial resistance (AMR) develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals.
As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights informs, educates and connects professionals around the globe with the aim to curb Antimicrobial resistance.
AMR Insights is committed to eliminating antimicrobial resistance because it does not accept that millions of innocent people need to die as a result of resistant bacteria and other microorganisms.
What’s New in Antimicrobial Resistance
AMR is a much-discussed topic, and this edition of our BioTuesday series aims to provide attendees a better understanding of a range of issues, including the factors holding the development of new medicines back and how the field will develop.
16/07/2019 - 16/07/2019 | Alderley Park (UK)
Antimicrobial Resistance in low and middle income countries: learning across microbes and a structure for action
Hear from Prof Chris Whitty, the new Chief Medical Officer for England and the UK government as he explores the topic antimicrobial resistance in low and middle income countries: learning accross microbes and structure for action.
16/07/2019 - 16/07/2019 | London (UK)
Achieving Universal Health Coverage while addressing Antimicrobial Resistance
This year’s conference will focus on the connection between achieving universal health coverage (UHC) and antimicrobial resistance (AMR). Specifically, the conference will focus on how addressing AMR is a path to attaining UHC and what country programs can be leveraged on.
23/07/2019 - 25/07/2019 | Nairobi (Kenia)
Latest news on AMR
Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan
Clinical Enterobacteriacae isolates with a colistin minimum inhibitory concentration (MIC) ≥4 mg/L from a United States hospital were screened for the mcr-1 gene using real-time polymerase chain reaction (RT-PCR) and confirmed by whole-genome sequencing.
Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study
Antibiotic prescribing has reduced and become more selective but substantial unnecessary AB use may persist. Improving the quality of diagnostic coding for AB use will help to support antimicrobial stewardship efforts.
Evaluating antimicrobial resistance in the global shrimp industry
Antimicrobial resistance (AMR) is a growing threat to global public health, and the overuse of antibiotics in animals has been identified as a major risk factor. With high levels of international trade and direct connectivity to the aquatic environment, shrimp aquaculture may play a role in global AMR dissemination.
Stay tuned with remarkable global AMR news and developments!